Orgenesis Inc
Change company Symbol lookup
Select an option...
ORGS Orgenesis Inc
LYFT Lyft Inc
AROC Archrock Inc
PACK Ranpak Holdings Corp
NVEE NV5 Global Inc
YARIY Yara International ASA
HYB New America High Income Fund
ACV Virtus Diversified Income & Convertible Fund
XLO Xilio Therapeutics Inc
ORN Orion Group Holdings Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Orgenesis Inc. is a global biotech company that is operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). It has developed a Point of Care Platform (POCare Platform) comprised of three enabling components, which includes a pipeline of POCare advanced therapies that are designed to be processed and produced, automated closed POCare technology systems, and a worldwide network of POCare research institutes and hospitals (POCare Network). Its products in clinical use include KYSLECEL, Tissue Genesis Icellator for Cell Assisted Lipotransfer, Cartil-S Autologous products for the treatment of osteoarthritis, and Chondroseal Autologous products for the treatment of cartilage defects.

Closing Price
$2.52
Day's Change
0.13 (5.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.54
Day's Low
2.45
Volume
(Light)
Volume:
23,051

10-day average volume:
35,350
23,051

KKR Real Estate Finance Trust Inc. to Announce First Quarter 2022 Results

7:50 pm ET April 5, 2022 (BusinessWire) Print

KKR Real Estate Finance Trust Inc. ("KREF") (NYSE: KREF) announced today that it plans to release its financial results for the first quarter 2022 on Monday, April 25, 2022, after the closing of trading on the New York Stock Exchange.

A conference call to discuss KREF's financial results will be held on Tuesday, April 26, 2022 at 10:00 a.m. ET. The conference call may be accessed by dialing (844) 784-1730 (U.S. callers) or +1 (412) 380-7410 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Relations section of KREF's website at http://www.kkrreit.com/investor-relations/events-and-presentations. A slide presentation containing supplemental information may also be accessed through this website in advance of the call.

A replay of the live broadcast will be available on KREF's website or by dialing (877) 344-7529 (U.S. callers) or +1 (412) 317-0088 (non-U.S. callers), pass code 9433785, beginning approximately two hours after the broadcast.

About KKR Real Estate Finance Trust Inc.

KREF is a real estate finance company that focuses primarily on originating and acquiring senior loans secured by commercial real estate properties. KREF is externally managed and advised by an affiliate of KKR & Co. Inc. For additional information about KREF, please visit its website at www.kkrreit.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220405006277/en/

SOURCE: KKR Real Estate Finance Trust Inc.

MEDIA: 
Cara Major or Miles Radcliffe-Trenner
(212) 750-8300
media@kkr.com

INVESTOR RELATIONS: 
Jack Switala
(212) 763-9048
kref-ir@kkr.com
comtex tracking

COMTEX_405278935/1006/2022-04-05T19:50:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.